- Home
- / Cambridge Cognition Holdings
Cambridge Cognition HoldingsCambridge Cognition Holdings
Revenue
£10.1 M
FY, 2021
Market Capitalization
£35.4 M
2023-01-26
Cambridge Cognition Holdings Summary
Company summary
- Overview
- Cambridge Cognition Holdings develops and commercializes computerized neuropsychological tests. Company delivers near-patient assessment solutions to improve the understanding, diagnosis, and treatment of neurological and psychiatric disorders.
- Type
- Public
- Status
- Active
- Founded
- 2002
- HQ
- Bottisham, GB | view all locations
- Cybersecurity rating
Key people
Steven Powell, Chairman
Debra Leeves, Non-Executive Director
Richard Bungay, Non-Executive Director
LocationsView all
2 locations detected
Bottisham, England HQ
United Kingdom
Tunbridge Court Tunbridge Ln
Cambridge, MA
United States
One Broadway, 1 Broadway
Cambridge Cognition Holdings Financials
Summary financials
- Revenue (H1, 2022)
- £5.9M
- Gross profit (H1, 2022)
- £4.7M
- Net income (H1, 2022)
- £16.0K
- Cash (H1, 2022)
- £8.6M
- EBIT (H1, 2022)
- £16.0K
- Enterprise value
- $26.8M
